Glossary in Investment

Financial Terms by:

Most Popular Terms in Investment

Category

Read the Latest Market Journal

Ever Glory United Holdings Ltd – Order Book Surges Past S$1bn

Published on Sep 4, 2026 11 

Brief Overview Ever Glory United Holdings delivered strong 1H26 results, with revenue and adjusted profit after tax and minority interest (PATMI) exceeding expectations at 84% and 94% of full-year forecasts respectively. The company's order book surged 220% year-on-year to more than S$1bn following the securing of over S$400mn in new contracts during 2026. Phillip Securities Research maintains a BUY recommendation with a raised target price of S$1.20. Investment Positives The primary driver of Ever Glory's growth has been the consolidation of Guthrie's results following the acquisition. The company's adjusted PATMI accelerated 208% year-on-year to S$14.1mn in 1H26, compared to 98% growth in 2H25. This growth was driven by the consolidation and recognition of Guthrie's mechanical and electrical (M&E) works, particularly progress on combined M&E projects including maintenance of street lighting and bus depot facility upgrades. The company's order book represents a significant positive, having surged more than 220% year-on-year to exceed S$1bn. Ever Glory secured more than S$400mn in new contracts during 2026, including S$168mn combined value for an offshore defence infrastructure project and M&E contracts in commercial mixed developments. This substantial order book is expected to support growth through 2029. The company has also strengthened its financial position, with net debt reducing by 86% year-on-year to S$716,000, supported by a S$19mn year-on-year increase in operating cash flow. This improved balance sheet has enabled Ever Glory to recommend interim dividends of 0.75 cents per share, representing a 29% payout ratio, compared to no interim dividend in 1H25. Investment Negatives The report does not explicitly outline specific investment negatives or risks facing Ever Glory United Holdings. Outlook Ever Glory appears well-positioned for continued growth, with management believing the company can secure additional high-value M&E contracts. Potential future awards include Integrated General Hospital projects worth more than S$200mn per M&E project, Changi T5 buildings and runway lighting worth S$1bn or more for M&E work, and LTA MRT tunnel lighting projects. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Ever Glory United Holdings with a raised target price of S$1.20, increased from the previous target of S$1.05. The analysts raised FY26 revenue and PATMI forecasts by 57% and 62% respectively due to the consolidation of Guthrie's results. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

Singapore REITs Monthly – Strong DPU Growth in 1H26

Published on Sep 4, 2026 9 

Brief Overview The Singapore REITs sector delivered a solid performance in July with the S-REITs Index gaining 3%, building on June's 0.4% increase. Results for 1H26 showed impressive strength, with S-REITs under coverage achieving approximately 6% average distribution per unit (DPU) growth year-on-year, excluding Prime US REIT's exceptional 316% growth. Phillip Securities Research maintains an overweight stance on the sector whilst remaining selective given uncertain interest rate conditions. Investment Positives The 1H26 results demonstrate the sector's underlying resilience, with DPU growth driven by three key factors. Financing costs declined by approximately 20 basis points year-on-year on average, providing material support to distributions. Operating performance remained resilient, supported by higher rents across portfolios. Additionally, completed asset enhancement initiatives (AEIs) and accretive acquisitions contributed meaningfully to growth. Individual REIT performance highlights the sector's momentum, with Suntec REIT and OUE REIT recording particularly strong DPU growth of 24.8% and 28.6% respectively, driven by lower financing costs and resilient performance across their Singapore assets. The 3-month SORA has stabilised at around 1.15%, remaining approximately 70 basis points lower year-on-year, continuing to benefit S-REITs with SGD-denominated loans through reduced borrowing costs. Transaction activity remains robust, with over S$8 billion of acquisitions and more than S$5 billion of divestments year-to-date, including significant deals such as CICT's S$3.9 billion acquisition of Paragon Mall. The retail sub-sector shows particularly strong fundamentals, with 1H26 performance characterised by near-full occupancy and rental reversions ranging from mid-single digits to low teens. This performance is underpinned by 17% growth in tenant sales, steady footfall, and limited new supply. The supply outlook remains favourable, with forecast average annual gross new supply of approximately 0.5 million square feet from 2026 to 2029, below historical averages. Investment Negatives Despite the positive momentum, analysts highlight concerns about interest rate volatility given the uncertain outlook. The macroeconomic backdrop remains volatile amid the possibility of a Federal Reserve rate hike, which could impact transaction momentum and financing costs. Outlook Analysts expect the positive momentum to continue into 2H26, forecasting approximately 4% average DPU growth for covered S-REITs, supported by organic rental growth, accretive acquisitions, and lower financing costs. Transaction activity is expected to continue but at a slower pace given macroeconomic uncertainties. For retail S-REITs specifically, FY26e rental reversions are expected to remain in the mid-to-high-single-digit range. Recommendation & Target Price Phillip Securities Research maintains an overweight recommendation on Singapore REITs, favouring those with robust balance sheets, defensive earnings profiles and high proportions of fixed-rate debt. The firm's top picks are Stoneweg Europe Stapled Trust (BUY, target price €1.89), Elite UK REIT (BUY, target price £0.41), and United Hampshire US REIT (BUY, target price US$0.69). Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

17LIVE Group Limited – Coverage Ceasing as Company Pursues Diversification Strategy

Published on Sep 4, 2026 6 

Brief Overview Phillip Securities Research has announced it will cease coverage of 17LIVE Group Limited following its latest results review. The company reported a 19.4% year-on-year revenue decline to US$65.4 million in 1H26, driven by falling active users and flat average revenue per user growth. Despite revenue challenges, the net loss narrowed significantly from US$4.6 million to US$1.6 million, supported by cost-optimisation efforts. The company is pursuing diversification through live commerce and AI-driven content production. Investment Positives The analyst highlights several encouraging developments for 17LIVE's operational efficiency and strategic direction. Cost-optimisation efforts have proven effective, with the company successfully narrowing its net loss by approximately 65% year-on-year from US$4.6 million in 1H25 to US$1.6 million in 1H26. This demonstrates management's ability to control expenses during a challenging period. The company's diversification strategy presents potential new revenue streams beyond its traditional livestreaming business. 17LIVE plans to expand into live commerce, which could provide additional monetisation opportunities. The company is also venturing into short-drama and AI-driven drama production, specifically targeting the Japanese market through revenue-sharing partnerships with short-drama platforms. Technology enhancements to the core business show promise for future growth. The company plans to launch AI Co-Host functionality and expand its 17Animaker tool more broadly. These innovations are designed to enhance streamer productivity and improve user engagement, potentially addressing some of the user retention challenges. Investment Negatives The core business metrics present significant concerns. Revenue declined substantially by 19.4% year-on-year to US$65.4 million in 1H26, indicating weakening demand for the company's services. This decline was driven by two critical factors: a reduction in active users and flat average revenue per user growth, suggesting both user acquisition and monetisation challenges. Profitability remains elusive despite cost-cutting measures. The company continued to be loss-making during 1H26, with earnings falling below analyst expectations compared to the FY26 forecast of US$3.8 million in profit after tax and minority interests. Outlook 17LIVE's 1H26 revenue represented 45% of the full-year FY26 forecast, indicating the company needs significant improvement in the second half to meet projections. The success of diversification initiatives, particularly in live commerce and Japanese short-drama partnerships, will be crucial for future performance. Recommendation & Target Price Following this report, Phillip Securities Research will cease coverage of 17LIVE due to the reallocation of coverage resources. No specific recommendation or target price was provided in this final coverage report. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

BRC Asia Ltd – PATMI accelerates, balance sheet strengthens

Published on Sep 4, 2026 5 

Brief Overview BRC Asia provided a 3Q26 update with limited financials, showing results within expectations. The company delivered 9M26 revenue and PATMI at 70% and 72% of full-year forecasts respectively. Notable developments included PATMI acceleration of 25% year-on-year to S$27.3 million, whilst revenue growth decelerated to 4.8% due to Changi T5 project timing issues. The company maintains a strong net cash position of S$60.4 million. Investment Positives BRC Asia demonstrated strong operational performance through accelerated PATMI growth of 25% year-on-year to S$27.3 million in 3Q26. This growth was driven by elevated steel rebar volumes delivered, which created operating leverage benefits. The company delivered an estimated 600,000 tons of steel rebar in 3Q26, representing a substantial 45% increase compared to the average of approximately 420,000 tons delivered quarterly over the past seven years. Profitability improvements were further supported by lower provisions for onerous contracts, contributing to gross margin expansion of 40 basis points year-on-year to 11.4%. This demonstrates the company's ability to improve operational efficiency whilst managing project risks. The balance sheet position has strengthened considerably. BRC Asia maintained its strong net cash position of S$60.4 million, improving from S$52 million in 1H26. This was supported by a significant rebound in 3Q26 operating cash flow to S$33 million, compared to negative S$8.5 million in 3Q25. This robust financial position enables the group to maintain its dividend payout ratio at 58% in FY26e, providing an attractive yield of approximately 5.5%. Investment Negatives Revenue growth momentum has decelerated significantly. 3Q26 revenue growth slowed to 4.8% year-on-year, marking the smallest growth rate since 2Q25. This deceleration was primarily attributed to reduced rebar volume growth, which dropped to approximately 3.5% year-on-year in 3Q26, compared to an estimated 46% in 2Q26. The slowdown resulted from a reorganisation of Changi T5 works, which affected project timing and delivery schedules. However, the analyst expects rebar volume delivery to strengthen in 4Q26e and into 1H27e as project offtake continues. Outlook The analyst believes BRC Asia's strong balance sheet provides sufficient headroom to maintain dividend distributions whilst supporting future growth. The temporary impact from Changi T5 project reorganisation is expected to resolve, with volume delivery anticipated to strengthen in upcoming quarters. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation with an unchanged DCF-derived target price of S$5.30. The analyst lowered FY26e revenue and PATMI forecasts by 5% and 3% respectively due to slight delays in the Changi T5 project. The WACC was reduced to 10.3% from 10.5% due to BRC Asia's stronger net cash position. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

ComfortDelGro Faces Persistent Taxi Headwinds Despite UK Bus Contract Improvements

Published on Sep 4, 2026 4 

Brief Overview ComfortDelGro Corp Ltd delivered underwhelming first-half results, with 1H26 revenue and PATMI reaching only 46% and 44% of full-year expectations respectively. The company's taxi operations remain severely challenged across multiple markets, whilst the UK bus business provided some relief through contract repricing. Management maintained the interim dividend at 3.91 cents despite the earnings decline. Investment Positives The primary bright spot remains ComfortDelGro's London bus operations, specifically through Metroline. The recontracting of Metroline London contracts to higher margins has successfully driven UK earnings growth, with public transport earnings advancing 11% higher in 1H26. Approximately 70% of the repricing process has been completed, indicating further potential benefits ahead. This strategic repricing demonstrates management's ability to negotiate improved terms in at least one segment of their diversified transport portfolio. Investment Negatives Taxi operations represent the company's most significant challenge, with earnings plummeting 46% year-on-year to S$36.6 million in 1H26. The weakness spans multiple geographic markets, creating a broad-based deterioration in this core segment. In Singapore, the taxi fleet continues shrinking, whilst Australia faces soft consumer demand pressures. The UK taxi operations encountered specific disruption through the A2B premium taxi service, where a major Middle Eastern airline customer cancelled flights or operated with reduced capacity due to Middle East conflict impacts. The company's substantial acquisition strategy has failed to deliver expected results, with approximately S$850 million worth of acquisitions not producing the anticipated earnings turnaround. Operating conditions have worsened across Australia and the UK markets, suggesting systemic rather than isolated challenges. Outlook The analyst expects taxi segment weakness to persist into the second half of 2H26, indicating no near-term recovery prospects. The structural headwinds affecting taxi operations are described as both worsening and spreading across markets, suggesting deeper industry-wide challenges rather than company-specific issues. Recommendation & Target Price Phillip Securities Research maintains a NEUTRAL recommendation on ComfortDelGro Corp Ltd. The target price has been reduced to S$1.21 from the previous S$1.35, reflecting deteriorating prospects. The firm has lowered FY26 earnings estimates by 7% to S$177 million. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

Hyphens Pharma International Maintains Growth Trajectory Despite Near-Term Headwinds

Published on Sep 4, 2026 4 

Brief Overview Hyphens Pharma International reported 1H26 results that met expectations, with revenue and adjusted profit after tax and minority interests (adj.PATMI) reaching 48% and 42% of full-year forecasts respectively. Revenue remained largely flat at S$89.1mn, whilst adj.PATMI declined 11% year-on-year due to increased distribution costs. The company is strategically building its product portfolio breadth and scale, though this requires higher upfront investments across multiple areas. Investment Positives The standout positive development was the achievement of record gross margins. Gross profit margin improved by 2.8 percentage points to reach a record 42.3%, driving gross profit up 6.6% to S$37.6mn. This margin expansion was supported by the company's strategic focus on higher-margin products, with prescription drugs under speciality pharma representing the highest-margin segment. The margin improvement also reflects the discontinuation of lower-margin products such as Physiolac, demonstrating management's commitment to portfolio optimisation. Key growth products driving the business forward include Cerapro MED for atopic dermatitis, Winlevi for anti-acne treatment, Ceradan for skin repair, and D-Cure vitamin D supplement. From a balance sheet perspective, Hyphens maintains a strong financial position with net cash of S$23mn, providing flexibility for continued investment and growth initiatives. Investment Negatives The primary headwind facing the company is rising operating expenses, which climbed 8% to S$30mn, representing an increase of S$2.2mn. This increase effectively offset the S$2.3mn gain in gross profit, highlighting the pressure on operating margins. The expense increases were driven by additional investments in marketing, which rose by S$1.1mn, and staff costs, which increased by S$1mn. These higher advertising and employee expenses pulled down operating profit despite the improved gross margins. Outlook Hyphens is positioned for stronger second-half earnings, with the company continuing to build the breadth and scale of its product offerings. The strategic investments in employee, marketing and research costs are expected to support longer-term growth prospects. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Hyphens Pharma International with a raised target price of S$0.46, up from the previous target after lowering DCF risk assumptions. The stock trades at an attractive valuation of 9x price-to-earnings ratio. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

SATS Ltd Shows Strong Cargo and Food Performance Despite SoAJV Challenges

Published on Sep 4, 2026 11 

Brief Overview SATS Ltd reported strong first-quarter results with revenue and PATMI rising 11.3% and 5.9% year-on-year to S$1,676.3 million and S$75.1 million respectively, representing 28% and 25% of full-year forecasts. Cargo volumes increased 8.6% year-on-year driven by Americas demand, whilst food solutions revenue grew 5.4% supported by non-aviation expansion. Food solutions margins improved significantly by 1.6 percentage points to 14.1% despite inflationary pressures. Investment Positives The analyst highlights strong operational performance across key business segments. Cargo volumes demonstrated robust growth of 8.6% year-on-year to 2,585.1 thousand tonnes, with particularly strong performance in the Americas region showing 9.5% year-on-year growth. This expansion was underpinned by high-value, time-sensitive freight including servers, data storage units and memory chips used for AI data centre build-out. Food solutions emerged as another strong performer with revenue rising 5.4% year-on-year to S$346 million. Non-aviation food revenue showed impressive 16% year-on-year growth, supported by customer expansion in China, including Starbucks. The higher non-aviation food volumes drove greater utilisation of SATS' central kitchen and food factories, which have largely fixed costs, creating operating leverage and lowering unit costs. Additionally, ongoing repricing negotiations and a rerouting-driven benefit in the long-haul meal mix supported performance. Investment Negatives The report indicates challenges from margin compression due to elevated M&A transaction costs and SOAJV weakness stemming from low-cost carrier exposure, which resulted in an 18.8% decline in operating profit for that segment. Outlook The analyst expects normalisation in the coming quarters as margin compression from elevated M&A transaction costs and SOAJV weakness from low-cost carrier exposure should improve. Stronger food segment volumes are anticipated from effective utilisation of new facilities, with forecasts increased for FY28e and FY29e PATMI by 1% and 5% respectively. Recommendation & Target Price Phillip Securities Research maintains a BUY rating and has raised the DCF target price to S$5.01 from the previous S$4.52. SATS currently trades at 20.2x FY27e P/E. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

StarHub Faces Revenue Decline Across All Divisions as Results Fall Short

Published on Sep 4, 2026 4 

Brief Overview StarHub Limited reported disappointing first-half results, with 1H26 revenue and EBITDA representing just 41% and 43% respectively of Phillip Securities Research's full-year forecasts. Revenue deterioration affected not only mobile services but all business divisions, with mobile service revenue declining 10.5% year-on-year to S$245 million. The analyst has lowered FY26e EBITDA estimates by 10% to S$325 million whilst raising the target price to S$1.07 from S$0.95. Investment Positives The analyst identified limited positive developments during the review period. StarHub reported that its mobile division was experiencing improved metrics due to 5G+ unlimited plans. The company indicated that transitioning customers to these premium plans was leading to higher customer satisfaction levels and fewer service-related issues. Management suggested this 5G+ strategy was gaining traction in the market. However, the analyst noted scepticism regarding these claimed benefits, as the financial results have not yet reflected any meaningful improvement from the 5G+ initiative. Investment Negatives The investment challenges facing StarHub are comprehensive, affecting all four business segments. Mobile services suffered the steepest decline, falling 10.5% year-on-year to S$245 million, whilst also declining 2% quarter-on-quarter in 2Q26. The broadband and entertainment division experienced an 8.5% year-on-year decline to S$208 million, with the securing of English Premier League rights failing to deliver any notable performance improvement. Underlying profitability deteriorated significantly, with PATMI collapsing by at least 74% year-on-year to S$12.4 million in 1H26, excluding contributions from Ensign. Mobile competition is creating substantial pressure across multiple revenue streams, including roaming, international direct dialling, voice and data subscriptions, and value-added services. Average revenue per user declined 5% quarter-on-quarter to S$20 per month, contradicting management's claims about 5G+ plan benefits. Outlook The analyst expects StarHub to dispose of its remaining stake in Ensign back to its parent company, potentially during FY26. The proceeds from this divestment could provide funding for future acquisitions and help revitalise mobile operations. Ensign currently represents a 38.92% associate holding for StarHub. Recommendation & Target Price Phillip Securities Research maintains a NEUTRAL recommendation on StarHub Limited. The target price has been raised to S$1.07 from the previous S$0.95, incorporating Ensign's book value at a 50% discount following the partial divestment. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.   Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.

Latest Videos

Join Events & Seminars

Learn best practices and latest market outlook from experts and special guests

Hear & Ask our Experts

Join live weekly market calls

Read Popular News & Reports, Technical Pulses

at www.stocksbnb.com

Subscribe to our YouTube Channel

New video every week

Follow us on

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com